Publications
Publications
Show Results For
- All HBS Web
(122)
- Faculty Publications (52)
←
Page 3 of 52
Results
- 01 Dec 2010
- Keynote Speech
Improving Health and Health Care: Who is Responsible? Who is Accountable?
By: Regina E. Herzlinger, Bruce Rosen, Avi Israeli and Steve Shortell
Keywords: Health
- December 2009 (Revised March 2025)
- Case
Phreesia: The Patient Intake Company
By: Regina E. Herzlinger, Sunaina Yarlagadda and Brian L. Walker
How should the co-founders of an organization that provides patient sign-in and billing services scale their company after five years of successfully targeting small private physician practices? Phreesia had deployed a direct mail and sales force strategy that resulted... View Details
- April 2009 (Revised April 2009)
- Case
Immusol and Novartis
By: Regina E. Herzlinger, Keyne M. Monson, Juan D. Betancourt and Victor Li
Should Immusol strive to become a fully integrated pharmaceutical company? How should a small pharmaceutical company structure a deal for its novel technology with the giant Novartis? View Details
- October 2003 (Revised March 2008)
- Case
Salick Cardiovascular Centers: Business Plan
By: Regina E. Herzlinger, Kaushik Sen, Alex Tkachenko and Carolyn Wolff
A seasoned health services entrepreneur develops a business plan for a cardiovascular-focused factory. Will it work? View Details
- August 2003 (Revised August 2006)
- Case
New Sector Alliance (A): An Entry into Health Care?
By: Regina E. Herzlinger, Stacy Smollin Schwartz and Jeffrey Cronin
Describes the structure of the U.S. health care system and presents a study of a nonprofit consulting firm that hopes to enter the health care system. Includes descriptions of hospitals, doctors, insurers, medical technology providers, medical devices, pharmaceuticals,... View Details
- August 2003 (Revised August 2006)
- Case
I've Got Rhythm: Selling Cardiac Rhythm Management Devices
By: Regina E. Herzlinger, William Lagor, Christopher Perry and Scott St. Germain
The head of sales and marketing in a large medical devices firm must decide how to assign his sales force. He compares selling in the pharma, specialty pharma, and device industries and analyzes the reasons for the differences. View Details
- October 2002 (Revised June 2003)
- Background Note
New Frontiers in Target Discovery and Validation
By: Regina E. Herzlinger, Niv Caviar, Jon Chatterton and Andrea Lynn
Explains Immusol and Novartis's technology. View Details
- September 2002 (Revised August 2014)
- Case
Cardinal Health (A): The Medicine Shoppe Acquisition
By: Regina E. Herzlinger, Miguel Abecasis and Brenda Cheng
Robert Walter, the founder and CEO of Cardinal Health, a pharmaceutical distributor, is contemplating the purchase of Medicine Shoppe, a chain of apothecaries. The purchase might be construed as competition against his own drugstore customers. But one of its many... View Details
- July 2002 (Revised August 2014)
- Case
WellSpace Treatment Centers for Complementary and Alternative Medicine (A)
By: Regina E. Herzlinger, Jun HuangPu and Bing Lin
How should WellSpace, a venture capital-backed purveyor of alternative health services, expand? Although it was nearing breakeven in its first location, the right business model remained unclear. View Details
- September 2001 (Revised April 2005)
- Case
ePhysician
By: Regina E. Herzlinger, Grady Clouse and Gayathri Koundinya
- August 2001 (Revised February 2020)
- Case
Consumer-Driven Health Care: Medtronic's Health Insurance Options
By: Regina E. Herzlinger, John Hurwitch and Seth Bokser
Describes the variety of health insurance plans that this medical device company offers, including a high-deductible, consumer-driven health plan with a health reimbursement account that also enables health care providers to quote their own prices. Asks students to... View Details
- February 1985 (Revised January 2024)
- Case
Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment
By: Regina E. Herzlinger, Joyce Lallman, Nancy Kane, Jefferson C. Grahling and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating In Health Care course book.
This note and case series enables readers to conduct... View Details